FDA Inspections
Foreign FDA Inspections: A Guide to FDA's Pre-Inspection Procedures
Compounding Pharmacies
Preparing for FDA's Proposed CGMP Regulations for Compounding Pharmacies
In the News
FDA Warning Letter & Enforcement Trends of 2017: A Year in Review
ANDA
Preventing FDA Refuse-to-File Decisions for NDAs, ANDAs, and BLAs: A Quick Guide
Quality Systems
Assessing the Applicability and Necessity of CGMP to Drug Compounding
Good Manufacturing Processes
[Webinar Snippet] Key QMS Components for Compounding Pharmacy CGMP Compliance
Data Integrity
4 Ways Data Integrity is Being Improved in Clinical Research
In the News
5 Items on FDA's 2018 Regulatory Agenda
Quality Systems
Quality System Centralization vs. Decentralization: The Pros & Cons
The FDA Group sets itself apart from traditional consulting firms through its client success and satisfaction rate, and its dedication to the life sciences.